B-cell lymphoma. Epcoritamab is a bispecific CD20-directed CD3 T-cell engager. Epcoritamab was co-developed by AbbVie and Genmab. Epcoritamab was approved...
13 KB (829 words) - 06:11, 1 July 2024
autoimmune diseases. Proprietary, marketed with partners: Epkinly/Tepkinly (epcoritamab) for the treatment of Relapsed/refractory diffuse large B-cell lymphoma...
26 KB (1,906 words) - 04:10, 19 June 2024
2027 and is awaiting approval from the Food and Drug Administration for epcoritamab, a blood-cancer therapy under development in partnership with Genmab...
41 KB (3,428 words) - 02:11, 30 August 2024
Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin Ipilimumab Isatuximab Loncastuximab tesirine Mirvetuximab...
12 KB (794 words) - 03:30, 2 September 2024
asthma Enoticumab mab human DLL4 Ensituximab mab chimeric MUC5AC cancer Epcoritamab Epkinly BiTE humanized CD3, CD20 Y diffuse large B-cell lymphoma Epitumomab...
136 KB (4,020 words) - 07:14, 15 August 2024
Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin Ipilimumab Isatuximab Loncastuximab tesirine Mirvetuximab...
12 KB (758 words) - 23:46, 14 March 2024
(USAN) Enzeevu Eohilia epafipase (INN) epalrestat (INN) epanolol (INN) epcoritamab (INN) epelestat (INN) eperezolid (INN) eperisone (INN) epervudine (INN)...
10 KB (468 words) - 20:41, 27 August 2024
emacizumab, amivantamab, tebentafusp, faricimab, teclistamab, mosunetuzumab, epcoritamab, glofitamab. Among the bsAb programs currently under development, the...
29 KB (3,349 words) - 19:04, 30 July 2024
tisagenlecleucel (Kymriah) treatment. Cell therapy Checkpoint inhibitor Epcoritamab Gene therapy Immune checkpoint Fox M (July 12, 2017). "New Gene Therapy...
83 KB (8,682 words) - 02:22, 1 September 2024
Teclistamab L01FX25 Mosunetuzumab L01FX26 Mirvetuximab soravtansine L01FX27 Epcoritamab L01FX28 Glofitamab L01FX29 Talquetamab L01FY01 Pertuzumab and trastuzumab...
12 KB (877 words) - 15:36, 25 January 2024
Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§ Enoblituzumab§ Epcoritamab Etaracizumab§ Farletuzumab§ Ficlatuzumab§ Flotetuzumab§ Gemtuzumab ozogamicin...
5 KB (368 words) - 15:29, 21 August 2024
Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§ Enoblituzumab§ Epcoritamab Etaracizumab§ Farletuzumab§ Ficlatuzumab§ Flotetuzumab§ Gemtuzumab ozogamicin...
3 KB (129 words) - 01:04, 19 July 2023
Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§ Enoblituzumab§ Epcoritamab Etaracizumab§ Farletuzumab§ Ficlatuzumab§ Flotetuzumab§ Gemtuzumab ozogamicin...
4 KB (241 words) - 13:42, 14 July 2024